Search in:

COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2018 - Issue 2: Special issue: Lung Health Workshop

Submit an article Journal homepage

Free access

2,192

Views

CrossRef citations to date

Altmetric

Reviews

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?

Ioannis E. VasileiadisDepartment of Cardiology, General Hospital of Thessaloniki G. Papanikolaou, Thessaloniki, GreeceCorrespondence[email protected]

https://orcid.org/0000-0003-3214-6701

Christos A. GoudisDepartment of Cardiology, General Hospital of Serres, Serres, Greece

Pinelopi T. GiannakopoulouDepartment of Cardiology, General Hospital of Thessaloniki G. Papanikolaou, Thessaloniki, Greece

Tong LiuTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China

Pages 148-156 | Received 08 Nov 2017, Accepted 19 Jan 2018, Published online: 09 Mar 2018

Cite this article
https://doi.org/10.1080/15412555.2018.1432034
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Hye-Jin Boo, Hye-Young Min, Su Jung Hwang, Hyo-Jong Lee, Jae-Won Lee, Sei-Ryang Oh, Choon-Sik Park, Jong-Sook Park, You Mie Lee & Ho-Young Lee. (2023) The tobacco-specific carcinogen NNK induces pulmonary tumorigenesis via nAChR/Src/STAT3-mediated activation of the renin-angiotensin system and IGF-1R signaling. Experimental & Molecular Medicine 55:6, pages 1131-1144.
Crossref

Frida Vilstrup, Christian Kjer Heerfordt, Peter Kamstrup, Caroline Hedsund, Tor Biering-Sørensen, Rikke Sørensen, Shailesh Kolekar, Ole Hilberg, Lars Pedersen, Thomas Kromann Lund, Tobias Wirenfeldt Klausen, Kristoffer Grundtvig Skaarup, Josefin Eklöf, Pradeesh Sivapalan & Jens-Ulrik Stæhr Jensen. (2023) Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study. BMJ Open Respiratory Research 10:1, pages e001428.
Crossref

Hongzhen Lv, Jingyi Huang, Miao Miao, Cheng Huang, Wenlu Hang & Yong Xu. (2023) Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ Open Respiratory Research 10:1, pages e001569.
Crossref

M. A. Bubnova, O. N. Kryuchkova, E. A. Itskova, Y. A. Lutai, E. U. Turna, N. V. Jukova & E. A. Kostyukova. (2022) Efficacy of perindopril/amlodipine and valsartan/amlodipine combinations in patients with a combination of arterial hypertension and chronic obstructive pulmonary disease. South Russian Journal of Therapeutic Practice 3:1, pages 42-49.
Crossref

S. E. Glova, L. A. Khaisheva, I. V. Razumovsky & S. V. Shlyk. (2022) Microcirculatory changes in patients with chronic obstructive pulmonary disease and arterial hypertension. South Russian Journal of Therapeutic Practice 3:1, pages 34-41.
Crossref

Marc W. Heidorn, Stefanie Steck, Felix Müller, Sven-Oliver Tröbs, Gregor Buch, Andreas Schulz, Sören Schwuchow-Thonke, Alexander Schuch, Konstantin Strauch, Irene Schmidtmann, Karl J. Lackner, Tommaso Gori, Thomas Münzel, Philipp S. Wild & Jürgen H. Prochaska. (2022) FEV1 Predicts Cardiac Status and Outcome in Chronic Heart Failure. Chest 161:1, pages 179-189.
Crossref

Alaa T. Abdelhafez, Asmaa M.S. Gomaa, Asmaa M. Ahmed, Manal M. Sayed & Marwa A. Ahmed. (2021) Pioglitazone and/or irbesartan ameliorate COPD-induced endothelial dysfunction in side stream cigarette smoke-exposed mice model. Life Sciences 280, pages 119706.
Crossref

Mathieu Kerneis & Gilles Montalescot. (2021) RAS inhibition and COVID-19: more questions than answers?. The Lancet Respiratory Medicine 9:8, pages 807-809.
Crossref

David M. MacDonald, Gary CollinsChris H. WendtJulian WolfsonRussell P. TracyFrank RhameSteven DeeksStacey A. RizzaZelalem TemesgenCaryn MorseAngelike P. LiappisIrini SeretiJason V. BakerKen M. Kunisaki. (2021) A Pilot Study of the Effects of Losartan Versus Placebo on Pneumoproteins in HIV: A Secondary Analysis of a Randomized Double Blind Study. AIDS Research and Human Retroviruses.
Crossref

Abdel G. Elkahloun & Juan M. Saavedra. (2020) Candesartan could ameliorate the COVID-19 cytokine storm. Biomedicine & Pharmacotherapy 131, pages 110653.
Crossref

Shannon W. FinksMark J. RumbakTimothy H. Self. (2020) Treating Hypertension in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine 382:4, pages 353-363.
Crossref

M. L. Hepworth, S. L. Passey, H. J. Seow & R. Vlahos. (2019) Losartan does not inhibit cigarette smoke-induced lung inflammation in mice. Scientific Reports 9:1.
Crossref

Anne Orholm Nielsen, Lars Pedersen, Birgitte Fischer Sode & Morten Dahl. (2019) β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals. EClinicalMedicine 7, pages 21-26.
Crossref

Mario Cazzola & Maria Gabriella Matera. (2018) Editorial overview: Respiratory: Pulmonary pharmacology – It is time for a breath of fresh air. Current Opinion in Pharmacology 40, pages iv-viii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?

Citations (14)

Articles from other publishers (14)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date